BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37823611)

  • 1. The landscape of human SVA retrotransposons.
    Chu C; Lin EW; Tran A; Jin H; Ho NI; Veit A; Cortes-Ciriano I; Burns KH; Ting DT; Park PJ
    Nucleic Acids Res; 2023 Nov; 51(21):11453-11465. PubMed ID: 37823611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of SINE-VNTR-Alu (SVA) Retrotransposons in Shaping the Human Genome.
    Gianfrancesco O; Geary B; Savage AL; Billingsley KJ; Bubb VJ; Quinn JP
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the role of a SINE-VNTR-Alu retrotransposon polymorphism as a biomarker of Parkinson's disease progression.
    Fröhlich A; Pfaff AL; Middlehurst B; Hughes LS; Bubb VJ; Quinn JP; Koks S
    Sci Rep; 2024 May; 14(1):10932. PubMed ID: 38740892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A SINE-VNTR-
    Hall A; Moore AK; Hernandez DG; Billingsley KJ; Bubb VJ; Quinn JP; Nabec North American Brain Expression Consortium
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SVA retrotransposons: Evolution and genetic instability.
    Hancks DC; Kazazian HH
    Semin Cancer Biol; 2010 Aug; 20(4):234-45. PubMed ID: 20416380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR Deletion of a SVA Retrotransposon Demonstrates Function as a
    Price E; Gianfrancesco O; Harrison PT; Frank B; Bubb VJ; Quinn JP
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrotransposition of marked SVA elements by human L1s in cultured cells.
    Hancks DC; Goodier JL; Mandal PK; Cheung LE; Kazazian HH
    Hum Mol Genet; 2011 Sep; 20(17):3386-400. PubMed ID: 21636526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage specific evolution of the VNTR composite retrotransposon central domain and its role in retrotransposition of gibbon LAVA elements.
    Lupan I; Bulzu P; Popescu O; Damert A
    BMC Genomics; 2015 May; 16(1):389. PubMed ID: 25981446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of retrotransposon insertion polymorphisms in whole genome sequencing data from individuals with amyotrophic lateral sclerosis.
    Savage AL; Iacoangeli A; Schumann GG; Rubio-Roldan A; Garcia-Perez JL; Al Khleifat A; Koks S; Bubb VJ; Al-Chalabi A; Quinn JP
    Gene; 2022 Nov; 843():146799. PubMed ID: 35963498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression Quantitative Trait Loci (eQTLs) Associated with Retrotransposons Demonstrate their Modulatory Effect on the Transcriptome.
    Koks S; Pfaff AL; Bubb VJ; Quinn JP
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring SVA Insertion Polymorphisms in Shaping Differential Gene Expressions in the Central Nervous System.
    Hughes LS; Fröhlich A; Pfaff AL; Bubb VJ; Quinn JP; Kõks S
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery.
    Raiz J; Damert A; Chira S; Held U; Klawitter S; Hamdorf M; Löwer J; Strätling WH; Löwer R; Schumann GG
    Nucleic Acids Res; 2012 Feb; 40(4):1666-83. PubMed ID: 22053090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating Hexanucleotide Repeat Number and Methylation within the X-Linked Dystonia-Parkinsonism (XDP)-Related SVA Retrotransposon in
    Lüth T; Laβ J; Schaake S; Wohlers I; Pozojevic J; Jamora RDG; Rosales RL; Brüggemann N; Saranza G; Diesta CCE; Schlüter K; Tse R; Reyes CJ; Brand M; Busch H; Klein C; Westenberger A; Trinh J
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Engineered SVA Trans-mobilization Assay.
    Bock A; Schumann GG
    Methods Mol Biol; 2016; 1400():203-22. PubMed ID: 26895056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The minimal active human SVA retrotransposon requires only the 5'-hexamer and Alu-like domains.
    Hancks DC; Mandal PK; Cheung LE; Kazazian HH
    Mol Cell Biol; 2012 Nov; 32(22):4718-26. PubMed ID: 23007156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mobile threat to genome stability: The impact of non-LTR retrotransposons upon the human genome.
    Konkel MK; Batzer MA
    Semin Cancer Biol; 2010 Aug; 20(4):211-21. PubMed ID: 20307669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hominoid composite non-LTR retrotransposons-variety, assembly, evolution, and structural determinants of mobilization.
    Ianc B; Ochis C; Persch R; Popescu O; Damert A
    Mol Biol Evol; 2014 Nov; 31(11):2847-64. PubMed ID: 25216663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of disease-associated SINE-VNTR-Alus.
    Pfaff AL; Singleton LM; Kõks S
    Exp Biol Med (Maywood); 2022 May; 247(9):756-764. PubMed ID: 35387528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of polymorphic SVA retrotransposons using a mobile element scanning method for SVA (ME-Scan-SVA).
    Ha H; Loh JW; Xing J
    Mob DNA; 2016; 7():15. PubMed ID: 27478512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the potential function of SVA retrotransposons to modulate gene expression patterns.
    Savage AL; Bubb VJ; Breen G; Quinn JP
    BMC Evol Biol; 2013 May; 13():101. PubMed ID: 23692647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.